Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
Clinical trial NCT04088604 · COMPLETED
Trial details
- NCT number
- NCT04088604
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2021-12-17
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.